Product Information
ZAVZPRET 10 MG NASAL SPRAY is a brand product labeled by Pfizer Inc., priced at $189.8284 per EA under NDC 00069350002. Its NADAC has been published 149 times since Oct 18, 2023.
FDA first approved this application on Mar 9, 2023.
Strength
10 mg/.1mL
Manufacturer
Pfizer Inc.NDC
00069350002
Classification
Brand
Dosage Form
SPRAY
Route
NASAL
Effective Date
8/19/2026
Active Ingredients
ZAVEGEPANT HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA216386FDA Approved
3/9/2023
On Market Since
6/1/2023
Pharmacological Classes
Price Statistics
The NADAC for ZAVZPRET 10 MG NASAL SPRAY has been published 149 times since Oct 18, 2023, and over the history we have for it it has risen 7.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $189.8284 per EA |
|---|---|
| All-time high | $190.2039 (Jun 10, 2026) |
| All-time low | $175.9432 (Oct 18, 2023) |
| 52-week high | $190.2039 |
| 52-week low | $181.0969 |
| Median price | $181.1099 |
| Average price | $181.0580 |
| Largest weekly change | +5.0% (Dec 31, 2025) |
| Weeks tracked | 149 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the zavegepant market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZAVZPRET 10 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for ZAVZPRET 10 MG NASAL SPRAY, manufactured by Pfizer Inc., is $189.8284 per EA (NDC 00069350002), effective Aug 19, 2026.
How has the price of ZAVZPRET 10 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for ZAVZPRET 10 MG NASAL SPRAY has risen 7.9%. It has been tracked across 149 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for ZAVZPRET 10 MG NASAL SPRAY?
Since Oct 18, 2023, the NADAC for ZAVZPRET 10 MG NASAL SPRAY has ranged from a low of $175.9432 (Oct 18, 2023) to a high of $190.2039 (Jun 10, 2026), with a median of $181.1099 per EA.
Are there cheaper alternatives to ZAVZPRET 10 MG NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of ZAVZPRET 10 MG NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZAVZPRET 10 MG NASAL SPRAY?
ZAVZPRET 10 MG NASAL SPRAY (NDC 00069350002) is labeled by Pfizer Inc., and CMS classifies it as a brand product.